EAES-SAGES Clinical Practice Guideline Update: Multi-Society Recommendations on Key Controversies in the Management of Diverticular Disease

Front

1 of 3 · Front

📘 GuidelineCh 1 · Colorectal, Anorectal & Pilonidal Disease

EAES-SAGES Clinical Practice Guideline Update: Multi-Society Recommendations on Key Controversies in the Management of Diverticular Disease

In one breath

A multi-society update on the key controversies in diverticular disease: no routine antibiotics for uncomplicated diverticulitis, elective resection for persistent symptoms after recurrent episodes or recovery from a first abscess, and no routine follow-up colonoscopy after a first uncomplicated episode.

Edition2026 Update

Issued byEuropean Association for Endoscopic Surgery (EAES) and SAGES, with AAST, CSSANZ, EAST, ESCP, UEG and WSES participation

Place of issueInternational

PublishedSurgical Endoscopy · 2026 (online 14 October 2026)

⏳ Pending verification

FACE COLOURS Front — the summary · Back 1 — what it covers + key recommendations · Back 2 — evidence, changes + source

Back 1

2 of 3 · Back 1

Back colours mark the reading sections — the chapter colour is the band and chip.

§1 · What it covers

This guideline covers symptomatic uncomplicated diverticular disease (SUDD), uncomplicated diverticulitis, recurrent symptoms, follow-up colonoscopy, abscess, and operative choices in complicated diverticulitis.

Applies to: Adults with diverticular disease and acute/recovered diverticulitis, inpatient and outpatient.

§2 · Key recommendations

Conditional recommendations suggest rifaximin or mesalamine rather than standard supportive care for SUDD.
no routine antibiotics for uncomplicated diverticulitis.
elective resection rather than observation for persistent symptoms after recurrent uncomplicated episodes.
no routine follow-up colonoscopy after a first uncomplicated episode.
and elective resection rather than surveillance after recovery from a first diverticular abscess.
The panel also considered Hartmann resection, primary anastomosis, and laparoscopic lavage in complicated disease, while incorporating the prior EAES/ESCP guidance.

FACE COLOURS Front — the summary · Back 1 — what it covers + key recommendations · Back 2 — evidence, changes + source

Back 2

3 of 3 · Back 2

Back colours mark the reading sections — the chapter colour is the band and chip.

§3 · Evidence & grading

GRADE evidence-to-decision framework; evidence ranged from very low to moderate certainty. All headline recommendations are conditional.

§4 · What changed in this edition

Compared with the previous EAES guidance, this update incorporates the prior EAES/ESCP guidance and re-answers the key controversies in diverticular disease (per the source record). A recommendation-by-recommendation change table: Not yet established — pending verification (full-text pass).

§5 · Source & working link

EAES-SAGES. EAES-SAGES Clinical Practice Guideline Update: Multi-Society Recommendations on Key Controversies in the Management of Diverticular Disease. Surg Endosc. 2026. doi:10.1007/s00464-026-13296-1.

Publisher — the record's original_url, carried verbatim ↗DOI — 10.1007/s00464-026-13296-1 ↗

Link check 2026-11-11: the publisher (SAGES) URL fetched live — HTTP 200. The record carried no DOI/PMID; a Crossref title search on 2026-11-11 returned an exact-title match (Surgical Endoscopy, 2026) — the DOI row was completed from Crossref and is marked in completions.

Source: Tamer-supplied guideline index, intake 2026-11-10 (record #3, Domain 01) · Card built 2026-11-11 (Wave D) from the record itself; the §5.2 verification pass (UpToDate + Medscape → Perplexity → Tamer decision) has not yet run on this card. Completed in verification: doi — Crossref title search, live 2026-11-11 — exact-title match. ⚑ Conflict flag on the source record (flag value: 'Yes' — universal across all 169 intake records). The intake queue filed this record under the appendicitis conflict, but this record's topic is diverticular disease; the flag's nature for this record is Not yet established — pending verification.

FACE COLOURS Front — the summary · Back 1 — what it covers + key recommendations · Back 2 — evidence, changes + source

gl-div01-eaes-sages-diverticular-2026GS.code · Guidelines

More in Division 1 · Colorectal, Anorectal & Pilonidal Disease

📘 GuidelineCh 1 · Colorectal, Anorectal & Pilonidal Disease⏳ Pending verification

2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer

The 2022 PSOGI consensus on HIPEC for colorectal peritoneal metastases: after complete cytoreductive surgery, HIPEC is conditionally recommended despite the negative PRODIGE-7 results — with short-duration high-dose oxaliplatin strongly rejected and mitomycin-C weakly favoured.

2022 Consensus · Peritoneal Surface Oncology Group International (PSOGI)

📘 GuidelineCh 1 · Colorectal, Anorectal & Pilonidal Disease⏳ Pending verification

INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases

The INDEPSO-ISPSM consensus on colorectal peritoneal metastases, written for Indian epidemiology and access: cytoreductive surgery for selected isolated or resectable disease, adjuvant systemic chemotherapy after CRS, and HIPEC outside trials only selectively — particularly at PCI 11–15.

2024 · Indian Network for Development of Peritoneal Surface Oncology (INDEPSO) and Indian Society of Peritoneal Surface Malignancies (ISPSM)

📘 GuidelineCh 1 · Colorectal, Anorectal & Pilonidal Disease⏳ Pending verification

Multi-Society Guideline on Cytoreductive Surgery and HIPEC: Methodology and Overview of the Results

The multi-society CRS/HIPEC guideline's methodology and overview paper: seven recommendations built by GRADE ADOLOPMENT — conditional for metachronous colorectal and gastric peritoneal metastases, strong for pseudomyxoma, peritoneal mesothelioma and advanced ovarian cancer after neoadjuvant chemotherapy.

2024 · PSOGI with the European Society of Surgical Oncology, ERN-EURACAN, the Society of Surgical Oncology and partner societies (14 countries)